ALLMedicine™ Mood Disorders Center

Dec 3rd, 2020 - Evidence from family and twin studies suggests that mood and anxiety disorders, and related temperamental factors may share common etiologic factors. We examine the familial aggregation and coaggregation of anxiety disorder subtypes and anxiety-re...

Dec 1st, 2020 - The study aimed at the identification of the risk factors present during delivery, which might be present in prophylactic programs concerning postpartum mood disorders. This was a retrospective comparative study. The study material included data r...

Nov 29th, 2020 - Mood disorders are characterized by heterogeneity in severity, symptoms and treatment response. The possibility of selecting the correct therapy on the basis of patient-specific biomarker may be a considerable step towards personalized psychiatry....

Nov 28th, 2020 - The aerial parts of Tilia americana var. mexicana (Malvaceae, formerly Tiliaceae) or "sirimo" are used in Mexican traditional medicine for the relief of mild symptoms of mental stress, commonly referred to as "nerve diseases". Individuals use this...

Nov 28th, 2020 - Mood disorders are often comorbid with alcohol use disorder (AUD) and play a considerable role in the development and maintenance of alcohol dependence and relapse. Because of this high comorbidity, it is necessary to determine shared and unique g...

Jan 10th, 2019 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on...

Oct 23rd, 2018 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on.

Sep 4th, 2018 - There is a new appreciation of the perimenopause—defined as the early and late menopause transition stages as well as the early postmenopause—as a window of vulnerability for the development of both depressive symptoms and major depressive episode.

Jun 11th, 2018 - Purpose The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO)...

Apr 24th, 2017 - Answer questions and earn CME/CNE Patients with breast cancer commonly use complementary and integrative therapies as supportive care during cancer treatment and to manage treatment-related side effects. However, evidence supporting the use of suc...

Dec 3rd, 2020 - Evidence from family and twin studies suggests that mood and anxiety disorders, and related temperamental factors may share common etiologic factors. We examine the familial aggregation and coaggregation of anxiety disorder subtypes and anxiety-re...

Dec 1st, 2020 - The study aimed at the identification of the risk factors present during delivery, which might be present in prophylactic programs concerning postpartum mood disorders. This was a retrospective comparative study. The study material included data r...

Nov 29th, 2020 - Mood disorders are characterized by heterogeneity in severity, symptoms and treatment response. The possibility of selecting the correct therapy on the basis of patient-specific biomarker may be a considerable step towards personalized psychiatry....

Nov 28th, 2020 - The aerial parts of Tilia americana var. mexicana (Malvaceae, formerly Tiliaceae) or "sirimo" are used in Mexican traditional medicine for the relief of mild symptoms of mental stress, commonly referred to as "nerve diseases". Individuals use this...

Nov 28th, 2020 - Mood disorders are often comorbid with alcohol use disorder (AUD) and play a considerable role in the development and maintenance of alcohol dependence and relapse. Because of this high comorbidity, it is necessary to determine shared and unique g...

Nov 16th, 2020 - Prescription opioid use increases the risk for major depressive disorder (MDD) and anxiety and stress-related disorders (ASRD), new genetic evidence shows. The findings also suggest MDD is a potential causal risk factor for increased prescription ...

Sep 24th, 2020 - Metabolic alterations linked to inflammation and lipid metabolism can distinguish depression from anxiety and determine disease severity, new research suggests.  Results from a Dutch study included 1400 participants with anxiety, depression, or bo...

Sep 24th, 2020 - Metabolic alterations linked to inflammation and lipid metabolism can distinguish depression from anxiety and determine disease severity, new research suggests.  Results from a Dutch study included 1400 participants with anxiety, depression, or bo...

Jul 29th, 2020 - Editor's note: This interview was originally published as part of MDEdge's Psychcast podcast series. In this episode, podcast host Lorenzo Norris, MD, assistant professor of psychiatry and behavioral sciences at George Washington University, Washi...

Jun 9th, 2020 - The antipsychotic lurasidone (Latuda, Sunovion Pharmaceuticals, Inc) has long-term efficacy in the treatment of bipolar depression (BD) in children and adolescents, new research suggests. In an open-label extension study involving patients aged 10...